10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q3 2011

Filing Information

Form Type	10-Q
Accession Number	`0000897101-11-001905`
Period End Date	20110930
Filing Date	20111109
Fiscal Year	2011
Fiscal Period	Q3
XBRL Instance	stj-20111001.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 70 Cash Flow Statement 66

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$35.35M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$46.67M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$959.53M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46,669 at October 1, 2011 and $35,354 at January 1, 2011	`AccountsReceivableNetCurrent`	$1.40B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46,669 at October 1, 2011 and $35,354 at January 1, 2011	`AccountsReceivableNetCurrent`	$1.33B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Inventories	`InventoryNet`	$667.54M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$658.76M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$196.60M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$214.74M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$165.54M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$216.46M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.91B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	318.87M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	329.02M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.40B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	329.02M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.22B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	318.87M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.43B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.03B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$900.42M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.32B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.39B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$922.12M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$987.06M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$387.71M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$431.45M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$8.57B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.10B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$79.64M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$84.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$297.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$177.57M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$66.96M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$8.21M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$320.32M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$301.35M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$348.93M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$319.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.02B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$987.87M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.43B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.92B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$305.08M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$310.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$435.06M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$456.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.19B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.67B	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 318,874,306 and 329,018,166 shares issued and outstanding at October 1, 2011 and January 1, 2011, respectively)	`CommonStockValueOutstanding`	$32.90M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 318,874,306 and 329,018,166 shares issued and outstanding at October 1, 2011 and January 1, 2011, respectively)	`CommonStockValueOutstanding`	$31.89M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$9.08M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$156.13M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.10B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.33B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$68.90M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$50.48M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$17.93M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$15.11M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.37B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.44B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$9.10B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$8.57B	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.24B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.38B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$3.81B	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$4.20B	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.11B	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$362.94M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.01B	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$339.82M	USD	1 Quarter
Special charges	`SpecialCharges`	$18.22M	USD	3 Qtrs
Special charges	`SpecialCharges`	$7.17M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$1.13B	USD	3 Qtrs
Total cost of sales	`CostOfGoodsSold`	$370.12M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$1.01B	USD	3 Qtrs
Total cost of sales	`CostOfGoodsSold`	$339.82M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.08B	USD	3 Qtrs
Gross profit	`GrossProfit`	$900.09M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.81B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.53B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$505.08M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$438.72M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.33B	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$150.13M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$456.47M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$528.39M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$176.32M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$4.40M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$4.40M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	3 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$53.55M	USD	3 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$21.38M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$298.98M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$956.77M	USD	3 Qtrs
Operating profit	`OperatingIncomeLoss`	$309.67M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$1.01B	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-11.11M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-51.66M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-70.98M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-19.51M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$287.87M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$290.15M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$958.09M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$885.79M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$79.49M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$185.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$257.10M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$63.68M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$208.38M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$700.79M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$226.47M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$700.99M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.70	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.14	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$2.15	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$2.13	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$2.13	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.69	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.63	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.63	USD	3 Qtrs
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.21	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	328.23M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.82M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	324.20M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.03M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.93M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.10M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.45M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	326.82M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$226.47M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$700.99M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$700.79M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$208.38M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$175.81M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$224.63M	USD	3 Qtrs
Amortization of debt (premium)/discount	`AmortizationOfDebtDiscountPremium`	$692.00K	USD	3 Qtrs
Amortization of debt (premium)/discount	`AmortizationOfDebtDiscountPremium`	$-4.05M	USD	3 Qtrs
Inventory step-up amortization	`InventoryStepUpAmortization`	$29.44M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$58.68M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$53.14M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$10.96M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$8.69M	USD	3 Qtrs
Gain on sale of investment	`AvailableForSaleSecuritiesGrossRealizedGains`	$4.93M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$4.40M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$4.40M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-24.18M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-7.44M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$89.31M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$52.83M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$18.64M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$10.65M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$51.68M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-57.95M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-68.05M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$22.68M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$22.14M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$977.00K	USD	3 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$19.54M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$791.56M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$941.15M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$236.00M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$226.30M	USD	3 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$128.90M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$32.36M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$113.57M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-468.77M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-268.37M	USD	3 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$285.81M	USD	3 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$107.34M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$8.69M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$10.96M	USD	3 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$809.20M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$137.78M	USD	3 Qtrs
Issuances/(payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$444.60M	USD	3 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$78.42M	USD	3 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$671.09M	USD	3 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$78.42M	USD	3 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$655.72M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$133.68M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-207.89M	USD	3 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.22M	USD	3 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.70M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$459.19M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$458.69M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$959.53M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$959.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.